Rapid communication Open Access
Like 0


Laboratory preparedness with quality-assured diagnostic assays is essential for controlling the current coronavirus disease (COVID-19) outbreak. We conducted an external quality assessment study with inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) samples to support clinical laboratories with a proficiency testing option for molecular assays. To analyse SARS-CoV-2 testing performance, we used an online questionnaire developed for the European Union project RECOVER to assess molecular testing capacities in clinical diagnostic laboratories.


Article metrics loading...

Loading full text...

Full text loading...



  1. European Centre for Disease Prevention and Control (ECDC). Laboratory support for COVID-19 in the EU/EEA. Stockholm: ECDC. [Accessed: 25 May 2020]. Available from: https://www.ecdc.europa.eu/en/novel-coronavirus/laboratory-support
  2. World Health Organization (WHO). 2019 novel coronavirus (2019-nCoV): strategic preparedness and response plan. Geneva: WHO. [Accessed: 14 Apr 2020]. Available from: https://www.who.int/publications-detail/strategic-preparedness-and-response-plan-for-the-new-coronavirus
  3. World Health Organization (WHO). Molecular assays to diagnose COVID-19: Summary table of available protocols. Geneva: WHO. [Accessed: 21 Apr 2020]. Available from: https://www.who.int/publications/m/item/molecular-assays-to-diagnose-covid-19-summary-table-of-available-protocols
  4. Foundation for Innovative New Diagnostics (FIND). COVID-19 diagnostics resource centre. Geneva: FIND. [Accessed: 25 May 2020]. Available from: https://www.finddx.org/covid-19/
  5. World Health Organization (WHO). Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Geneva: WHO; 19 Mar 2020. Available from: https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117
  6. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3):2000045.  https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045  PMID: 31992387 
  7. Drosten C, Doerr HW, Lim W, Stöhr K, Niedrig M. SARS molecular detection external quality assurance. Emerg Infect Dis. 2004;10(12):2200-3. . Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323363/pdf/04-0416.pdf https://doi.org/10.3201/eid1012.040416  PMID: 15663861 
  8. US Food and Drug Administration (FDA). Coronavirus disease 2019 (COVID-19) EUA information. Silver Spring: FDA. [Accessed: 2 Jun 2020]. Available from: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#covidinvitrodev
  9. Wang X, Yao H, Xu X, Zhang P, Zhang M, Shao J, et al. Limits of detection of 6 approved RT-PCR kits for the novel SARS-coronavirus-2 (SARS-CoV-2). Clin Chem. 2020;66(7):977-9.  https://doi.org/10.1093/clinchem/hvaa099  PMID: 32282874 
  10. Pfefferle S, Reucher S, Nörz D, Lütgehetmann M. Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system. Euro Surveill. 2020;25(9):2000152.  https://doi.org/10.2807/1560-7917.ES.2020.25.9.2000152  PMID: 32156329 
  11. Matheeussen V, Loens K, Lammens C, Vilken T, Koopmans M, Goossens H, et al. Preparedness of European diagnostic microbiology labs for detection of SARS-CoV-2, March 2020. J Clin Virol. 2020;128:104432.  https://doi.org/10.1016/j.jcv.2020.104432  PMID: 32422569 
  12. Quality Control for Molecular Diagnostics (QCMD). Respiratory special. Glasgow: QCMD; 2020 [Accessed 25 June 2020]. Available from: https://www.qcmd.org/#fragment-2

Data & Media loading...

Supplementary data

Submit comment
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error